Gearing up for third vaccine doses for the immunocompromisedEligible patients will require a letter from their physician to receive a third dose, but pharmacists can assist in identifying candidates Getting a COVID-19 vaccine may be good for mental healthNew research is showing that even a first dose can ease mental distress Quiz: How much do you know about PrEP and HIV? How much do you know about pre-exposure prophylaxis (PrEP) to prevent HIV in people at high risk for the infection? Cross-country snapshot of unvaccinated Canadian healthcare workers Many are not immune to COVID-19 conspiracy theories and misinformation. Pfizer COVID-19 vaccine unlikely to cause relapse of Guillain-Barré syndrome Study suggests minimal risk of relapse when Pfizer-BioNTech mRNA COVID-19 vaccine is given to patients with a history of GBS. Ivermectin: efficacy and safety data lacking for COVID-19 prevention or treatment Health Canada advises consumers not use veterinary or human dosage forms of ivermectin to prevent or treat COVID-19. Vaccine hesitancy highest in Alberta, racialized groups at rollout's start: survey The survey, led by researchers at Toronto's St. Michael's Hospital, was published online Tuesday in The Lancet Regional Health–Americas. One jab has almost no effect against Delta: study According to a recently published study, two shots are better than one when it comes to protection against the SARS-CoV-2 Delta, as well as other, variants of the virus. J&J: Potential HIV vaccine falls short in mid stage study The study in sub-Saharan Africa involved about 2,600 women who were deemed to be at high risk of acquiring HIV, which causes AIDS. Six things to tell patients about the Delta variant of SARS-CoV-2 Spreads faster than early forms of SARS-CoV-2 and is now the predominant variant in Canada and the United States First Previous 47 48 49 50 51 Next Last
